{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T19:43:22Z","timestamp":1784058202289,"version":"3.55.0"},"reference-count":30,"publisher":"Impact Journals, LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2021,1,31]]},"DOI":"10.18632\/aging.103986","type":"journal-article","created":{"date-parts":[[2021,1,23]],"date-time":"2021-01-23T19:11:56Z","timestamp":1611429116000},"page":"1898-1912","source":"Crossref","is-referenced-by-count":12,"title":["Effective natural inhibitors targeting poly ADP-ribose polymerase by computational study"],"prefix":"10.18632","volume":"13","author":[{"given":"Sheng","family":"Zhong","sequence":"first","affiliation":[{"name":"Neurosurgery and Neuro-Oncology Department, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Wu","sequence":"additional","affiliation":[{"name":"Clinical College, Jilin University, Changchun, China"},{"name":"Department of Orthopaedics, The First Hospital of Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenzhuo","family":"Yang","sequence":"additional","affiliation":[{"name":"Clinical College, Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junliang","family":"Ge","sequence":"additional","affiliation":[{"name":"Clinical College, Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiangheng","family":"Zhang","sequence":"additional","affiliation":[{"name":"Neurosurgery and Neuro-Oncology Department, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenghe","family":"Chen","sequence":"additional","affiliation":[{"name":"Neurosurgery and Neuro-Oncology Department, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Duan","sequence":"additional","affiliation":[{"name":"Neurosurgery and Neuro-Oncology Department, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhenqiang","family":"He","sequence":"additional","affiliation":[{"name":"Neurosurgery and Neuro-Oncology Department, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yibing","family":"Liu","sequence":"additional","affiliation":[{"name":"Clinical College, Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Wang","sequence":"additional","affiliation":[{"name":"Clinical College, Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuting","family":"Jiang","sequence":"additional","affiliation":[{"name":"Clinical College, Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyun","family":"Zhang","sequence":"additional","affiliation":[{"name":"Clinical College, Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhui","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Oncology, The First Bethune Hospital of Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihang","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Orthopaedics, Xijing Hospital, The Fourth Military Medical University, Xi\u2019an, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naimeng","family":"Liu","sequence":"additional","affiliation":[{"name":"Clinical College, Jilin University, Changchun, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Guo","sequence":"additional","affiliation":[{"name":"Neurosurgery and Neuro-Oncology Department, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yonggao","family":"Mou","sequence":"additional","affiliation":[{"name":"Neurosurgery and Neuro-Oncology Department, Sun Yat-Sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2021,1,23]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"803","DOI":"10.1007\/s00401-016-1545-1","article-title":"The 2016 world health organization classification of tumors of the central nervous system: a summary.","volume":"13","author":"Ellison","year":"2016","journal-title":"Acta Neuropathol"},{"key":"2","doi-asserted-by":"publisher","first-page":"15","DOI":"10.3390\/brainsci8010015","article-title":"Glioblastoma under siege: an overview of current therapeutic strategies.","volume":"8","author":"Schinelli","year":"2018","journal-title":"Brain Sci"},{"key":"3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1007\/s10143-017-0928-7","article-title":"Multiple high-grade gliomas: epidemiology, management, and outcome. A systematic review and meta-analysis.","volume":"4","author":"Perrini","year":"2019","journal-title":"Neurosurg Rev"},{"key":"4","doi-asserted-by":"publisher","first-page":"372","DOI":"10.1016\/j.ijpharm.2017.07.056","article-title":"Breaching barriers in glioblastoma. Part I: Molecular pathways and novel treatment approaches.","volume":"53","author":"Vitorino","year":"2017","journal-title":"Int J Pharm"},{"key":"5","doi-asserted-by":"publisher","first-page":"1152","DOI":"10.1126\/science.aam7344","article-title":"PARP inhibitors: synthetic lethality in the clinic.","volume":"35","author":"Ashworth","year":"2017","journal-title":"Science"},{"key":"6","doi-asserted-by":"publisher","first-page":"4079","DOI":"10.1007\/s00018-012-1003-8","article-title":"poly(ADP-ribose) polymerase-2: emerging transcriptional roles of a DNA-repair protein.","volume":"6","author":"Bai","year":"2012","journal-title":"Cell Mol Life Sci"},{"key":"7","doi-asserted-by":"publisher","first-page":"1951","DOI":"10.1101\/gad.1331805","article-title":"poly(ADP-ribosyl)ation by PARP-1: \u2018PAR-laying\u2019 NAD+ into a nuclear signal.","volume":"1","author":"Kraus","year":"2005","journal-title":"Genes Dev"},{"key":"8","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1038\/nrd4201","article-title":"Targeting tumour-supportive cellular machineries in anticancer drug development.","volume":"1","author":"Moll","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"9","doi-asserted-by":"publisher","first-page":"3893","DOI":"10.1021\/bi972383s","article-title":"Inhibitor and NAD+ binding to poly(ADP-ribose) polymerase as derived from crystal structures and homology modeling.","volume":"3","author":"Schulz","year":"1998","journal-title":"Biochemistry"},{"key":"10","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1007\/s40265-015-0345-6","article-title":"Olaparib: first global approval.","volume":"7","author":"Deeks","year":"2015","journal-title":"Drugs"},{"key":"11","doi-asserted-by":"publisher","first-page":"244","DOI":"10.1200\/JCO.2014.56.2728","article-title":"Olaparib monotherapy in patients with advanced cancer and a germline BRCA1\/2 mutation.","volume":"3","author":"Loman","year":"2015","journal-title":"J Clin Oncol"},{"key":"12","doi-asserted-by":"publisher","first-page":"3916","DOI":"10.1158\/1078-0432.CCR-07-4953","article-title":"Selective inhibition of BRCA2-deficient mammary tumor cell growth by AZD2281 and cisplatin.","volume":"1","author":"Lau","year":"2008","journal-title":"Clin Cancer Res"},{"key":"13","doi-asserted-by":"publisher","first-page":"949","DOI":"10.2217\/fon.13.69","article-title":"Natural products and cancer drug discovery. 2013","volume":"9","author":"Newman","journal-title":"Future Oncology"},{"key":"14","doi-asserted-by":"publisher","first-page":"392","DOI":"10.2174\/1574892813666180305165256","article-title":"PARP inhibitors in ovarian cancer.","volume":"1","author":"Valabrega","year":"2018","journal-title":"Recent Pat Anticancer Drug Discov"},{"key":"15","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s00404-013-2856-2","article-title":"Olaparib: a promising PARP inhibitor in ovarian cancer therapy.","volume":"28","author":"Hao","year":"2013","journal-title":"Arch Gynecol Obstet"},{"key":"16","doi-asserted-by":"crossref","unstructured":"Montagnoli, Rainoldi, Ciavolella, Ballinari, Papeo. Abstract 1223: NMS-P293, a novel potent and selective PARP-1 inhibitor with high antitumor efficacy and tolerability Cancer Research. 2016. https:\/\/doi.org\/10.1158\/1538-7445.AM2016-1223.","DOI":"10.1158\/1538-7445.AM2016-1223"},{"key":"17","unstructured":"Shirui, Xiaowen. PARP Family and Clinically Used PARP Inhibitors Guangdong Chemical Industry. 2019; 46:134-136."},{"key":"18","doi-asserted-by":"publisher","first-page":"2655","DOI":"10.1016\/j.jmb.2019.05.028","article-title":"A single-molecule atomic force microscopy study of PARP1 and PARP2 recognition of base excision repair DNA intermediates.","volume":"43","author":"Lavrik","year":"2019","journal-title":"J Mol Biol"},{"key":"19","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.1038\/s41467-020-15429-z","article-title":"Differential regulation of breast cancer bone metastasis by PARP1 and PARP2.","volume":"1","author":"Wan","year":"2020","journal-title":"Nat Commun"},{"key":"20","doi-asserted-by":"publisher","first-page":"731","DOI":"10.1186\/s12885-019-5936-2","article-title":"Long non-coding RNA PTTG3P functions as an oncogene by sponging miR-383 and up-regulating CCND1 and PARP2 in hepatocellular carcinoma.","volume":"1","author":"Liu","year":"2019","journal-title":"BMC Cancer"},{"key":"21","doi-asserted-by":"publisher","first-page":"5243","DOI":"10.1002\/jcb.26585","article-title":"microRNA-383 suppresses the PI3K-AKT-MTOR signaling pathway to inhibit development of cervical cancer via down-regulating PARP2.","volume":"11","author":"Tang","year":"2018","journal-title":"J Cell Biochem"},{"key":"22","doi-asserted-by":"publisher","first-page":"9738","DOI":"10.18632\/aging.102422","article-title":"Selected by gene co-expression network and molecular docking analyses, ENMD-2076 is highly effective in glioblastoma-bearing rats.","volume":"1","author":"Zhao","year":"2019","journal-title":"Aging (Albany NY)"},{"key":"23","doi-asserted-by":"publisher","first-page":"e0216678","DOI":"10.1371\/journal.pone.0216678","article-title":"Computational study on new natural compound agonists of stimulator of interferon genes (STING).","volume":"1","author":"Jin","year":"2019","journal-title":"PLoS One"},{"key":"24","doi-asserted-by":"publisher","first-page":"923","DOI":"10.1038\/nrd3868","article-title":"Tankyrase-targeted therapeutics: expanding opportunities in the PARP family.","volume":"1","author":"Ashworth","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"25","doi-asserted-by":"publisher","first-page":"2159","DOI":"10.1021\/ci6004299","article-title":"Validation studies of the site-directed docking program LibDock.","volume":"4","author":"LaLonde","year":"2007","journal-title":"J Chem Inf Model"},{"key":"26","doi-asserted-by":"publisher","first-page":"1545","DOI":"10.1002\/jcc.21287","article-title":"CHARMM: the biomolecular simulation program.","volume":"3","author":"Cui","year":"2009","journal-title":"J Comput Chem"},{"key":"27","doi-asserted-by":"publisher","first-page":"e74761","DOI":"10.1371\/journal.pone.0074761","article-title":"In silico and in vivo anti-malarial studies of 18\u03b2 glycyrrhetinic acid from glycyrrhiza glabra.","volume":"8","author":"Srivastava","year":"2013","journal-title":"PLoS One"},{"key":"28","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1007\/s10822-014-9807-2","article-title":"Identification of ligand efficient, fragment-like hits from an HTS library: structure-based virtual screening and docking investigations of 2H- and 3H-pyrazolo tautomers for aurora kinase a selectivity.","volume":"2","author":"Coumar","year":"2015","journal-title":"J Comput Aided Mol Des"},{"key":"29","doi-asserted-by":"publisher","first-page":"1092","DOI":"10.1021\/ci100469n","article-title":"Predicting fragment binding poses using a combined MCSS MM-GBSA approach.","volume":"5","author":"Hubbard","year":"2011","journal-title":"J Chem Inf Model"},{"key":"30","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1021\/ci100275a","article-title":"Assessing the performance of the MM\/PBSA and MM\/GBSA methods. 1. The accuracy of binding free energy calculations based on molecular dynamics simulations.","volume":"5","author":"Wang","year":"2011","journal-title":"J Chem Inf Model"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.103986","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T16:07:06Z","timestamp":1617725226000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.103986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,23]]},"references-count":30,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,1,31]]}},"alternative-id":["103986","33486472"],"URL":"https:\/\/doi.org\/10.18632\/aging.103986","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,23]]}}}